DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica
Endocrinology Newsmakers: Drugmakers work on triple agonist treatments, gene therapies to fight diabetes
Endocrinology, a medicinal
branch that deals with endocrine and metabolic disorders, is witnessing
America’s drug price hike conundrum in backdrop of 2019 Medicare Part D data
Nearly every
year, drugmakers ring in the new year with drug price increases in the US. This
year
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
COVID-19: India restricts drug exports amid rising prices of essential bulk drugs; FDA announces first drug shortage
Now that it has been
established that the novel coronavirus is going to globally impact the drug
s
Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016
This week, PharmaCompass
reviews the recently released data on prescription drugs paid for under th
Ghosts of GSK’s billion dollar mistake return; New date for electronic submissions of DMFs
This week, Phispers tells us why David Hung’s taking charge as CEO of Axovant could signal the
EU suspends drugs from Granules’ Indian facility where FDA had no concerns
In October
2016, the US Food and Drug Administration (FDA) inspected a facility in India
belonging t
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the
President of the United States. He